世界中の市場調査レポートを販売!当社に無いレポートもお探しします。

レポートナンバー 0000040410

高分子注射薬の世界市場(2024-2028)

TechNavio

Global Large Molecule Injectable Drugs Market 2024-2028

発刊日 2024/07/27

言語英語

体裁PDF/166ページ

ライセンス/価格166ページ

0000040410

Single
Enterprise

※ご請求は、お申込日のTTSレートで円換算し、消費税を加えた金額になります。
※本レポートは、英文です。PDF(電子媒体)での納品となります。
※本レポートは取り寄せとなりますので、申し込みからお届けまで、多少時間が掛かる場合がございます。

無料サンプル

  • サンプルはお問い合わせください。

レポート概要

高分子注射薬市場は、2023年から2028年の間に2,556億米ドル成長すると予測されており、予測期間中に9.45%のCAGRで加速すると予測されています。このレポートは、全体的な分析、市場規模と予測、傾向、成長ドライバー、課題、および約25のベンダーをカバーするベンダー分析を提供します。

このレポートは、現在の市場シナリオ、最新の傾向と推進力、および全体的な市場環境に関する最新の分析を提供します。市場は、新興国からの需要の増加、医薬品の研究開発への投資の増加、遺伝子治療や細胞治療の進歩によって牽引されています。

調査範囲

  • 市場セグメント
    ➣ エンドユーザー別
      ◇ 病院薬局
      ◇ 小売薬局
      ◇ 電子商取引
    ➣ タイプ別
      ◇ 静脈内注射
      ◇ 筋肉注射
      ◇ 皮下注射
    ➣ 地域別
      ◇ 北アメリカ
      ◇ アジア
      ◇ ヨーロッパ
      ◇ その他の地域

この調査は、精密医療と個別化治療への注目の高まりが、今後数年間で高分子注射薬市場の成長を促進する主な理由の1つであることを特定しています。また、関係者間のパートナーシップと協力の増加、および消費者によるヘルスケアへの高額支出は、市場でのかなりの需要につながるでしょう。

高分子注射薬市場に関するレポートは、次の分野をカバーしています。

  • 高分子注射薬市場の規模
  • 高分子注射薬市場の予測
  • 高分子注射薬市場の業界分析

堅牢なベンダー分析は、クライアントが市場での地位を向上させるのに役立つように設計されています。

  • 調査企業
    ➣ AbbVie Inc.
    ➣ Amgen Inc.
    ➣ AstraZeneca Plc
    ➣ Baxter International Inc.
    ➣ Biogen Inc.
    ➣ Boehringer Ingelheim International GmbH
    ➣ Bristol Myers Squibb Co.
    ➣ Eli Lilly and Co.
    ➣ F. Hoffmann La Roche Ltd.
    ➣ Gilead Sciences Inc.
    ➣ GlaxoSmithKline Plc
    ➣ Johnson and Johnson Services Inc.
    ➣ Medtronic Plc
    ➣ Merck and Co. Inc.
    ➣ Novartis AG
    ➣ Novo Nordisk AS
    ➣ Pfizer Inc.
    ➣ Sanofi S
    ➣ Sun Pharmaceutical Industries Ltd.
    ➣ 武田製薬工業(Takeda Pharmaceutical Co. Ltd.)

また、本レポートには、市場の成長に影響を与える今後の傾向と課題に関する情報が含まれています。これは、企業が今後のすべての成長機会を戦略化し、活用するのに役立ちます。

この調査は、業界の主要参加者からの意見を含む一次情報と二次情報を客観的に組み合わせて実施されました。このレポートには、主要ベンダーの分析に加えて、包括的な市場とベンダーの状況が含まれています。

このレポートは、利益、価格設定、競争、プロモーションなどの主要なパラメーターの分析による複数のソースからのデータの調査、合成、合計により、市場の詳細な全体像を提示します。業界の主要な影響力を持つ企業を特定することで、さまざまな市場の側面を示します。提示されたデータは包括的で信頼性が高く、一次および二次の両方にわたる広範な研究の結果です。市場調査レポートは、正確な市場の成長を予測するための定性的および定量的調査を使用した、完全な競争状況と詳細なベンダー選択方法論および分析を提供します。

レポート詳細

目次

Table of Contents

1 Executive Summary
1.1 Market overview
Executive Summary - Chart on Market Overview
Executive Summary - Data Table on Market Overview
Executive Summary - Chart on Global Market Characteristics
Executive Summary - Chart on Market By Geographical Landscape
Executive Summary - Chart on Market Segmentation by End-user
Executive Summary - Chart on Market Segmentation by Type
Executive Summary - Chart on Incremental Growth
Executive Summary - Data Table on Incremental Growth
Executive Summary - Chart on Company Market Positioning

2 Market Landscape
2.1 Market ecosystem
Parent Market
Data Table on - Parent Market
2.2 Market characteristics
Market characteristics analysis
2.3 Value chain analysis
Value Chain Analysis

3 Market Sizing
3.1 Market definition
Offerings of companies included in the market definition
3.2 Market segment analysis
Market segments
3.3 Market size 2023
3.4 Market outlook: Forecast for 2023-2028
Chart on Global - Market size and forecast 2023-2028 ($ billion)
Data Table on Global - Market size and forecast 2023-2028 ($ billion)
Chart on Global Market: Year-over-year growth 2023-2028 (%)
Data Table on Global Market: Year-over-year growth 2023-2028 (%)

4 Historic Market Size
4.1 Global Large Molecule Injectable Drugs Market 2018 - 2022
Historic Market Size - Data Table on Global Large Molecule Injectable Drugs Market 2018 - 2022 ($ billion)
4.2 End-user segment analysis 2018 - 2022
Historic Market Size - End-user Segment 2018 - 2022 ($ billion)
4.3 Type segment analysis 2018 - 2022
Historic Market Size - Type Segment 2018 - 2022 ($ billion)
4.4 Geography segment analysis 2018 - 2022
Historic Market Size - Geography Segment 2018 - 2022 ($ billion)
4.5 Country segment analysis 2018 - 2022
Historic Market Size - Country Segment 2018 - 2022 ($ billion)

5 Five Forces Analysis
5.1 Five forces summary
Five forces analysis - Comparison between 2023 and 2028
5.2 Bargaining power of buyers
Bargaining power of buyers - Impact of key factors 2023 and 2028
5.3 Bargaining power of suppliers
Bargaining power of suppliers - Impact of key factors in 2023 and 2028
5.4 Threat of new entrants
Threat of new entrants - Impact of key factors in 2023 and 2028
5.5 Threat of substitutes
Threat of substitutes - Impact of key factors in 2023 and 2028
5.6 Threat of rivalry
Threat of rivalry - Impact of key factors in 2023 and 2028
5.7 Market condition
Chart on Market condition - Five forces 2023 and 2028

6 Market Segmentation by End-user
6.1 Market segments
Chart on End-user - Market share 2023-2028 (%)
Data Table on End-user - Market share 2023-2028 (%)
6.2 Comparison by End-user
Chart on Comparison by End-user
Data Table on Comparison by End-user
6.3 Hospital pharmacies - Market size and forecast 2023-2028
Chart on Hospital pharmacies - Market size and forecast 2023-2028 ($ billion)
Data Table on Hospital pharmacies - Market size and forecast 2023-2028 ($ billion)
Chart on Hospital pharmacies - Year-over-year growth 2023-2028 (%)
Data Table on Hospital pharmacies - Year-over-year growth 2023-2028 (%)
6.4 Retail pharmacies - Market size and forecast 2023-2028
Chart on Retail pharmacies - Market size and forecast 2023-2028 ($ billion)
Data Table on Retail pharmacies - Market size and forecast 2023-2028 ($ billion)
Chart on Retail pharmacies - Year-over-year growth 2023-2028 (%)
Data Table on Retail pharmacies - Year-over-year growth 2023-2028 (%)
6.5 E-commerce - Market size and forecast 2023-2028
Chart on E-commerce - Market size and forecast 2023-2028 ($ billion)
Data Table on E-commerce - Market size and forecast 2023-2028 ($ billion)
Chart on E-commerce - Year-over-year growth 2023-2028 (%)
Data Table on E-commerce - Year-over-year growth 2023-2028 (%)
6.6 Market opportunity by End-user
Market opportunity by End-user ($ billion)
Data Table on Market opportunity by End-user ($ billion)

7 Market Segmentation by Type
7.1 Market segments
Chart on Type - Market share 2023-2028 (%)
Data Table on Type - Market share 2023-2028 (%)
7.2 Comparison by Type
Chart on Comparison by Type
Data Table on Comparison by Type
7.3 Intravenous injection - Market size and forecast 2023-2028
Chart on Intravenous injection - Market size and forecast 2023-2028 ($ billion)
Data Table on Intravenous injection - Market size and forecast 2023-2028 ($ billion)
Chart on Intravenous injection - Year-over-year growth 2023-2028 (%)
Data Table on Intravenous injection - Year-over-year growth 2023-2028 (%)
7.4 Muscle injection - Market size and forecast 2023-2028
Chart on Muscle injection - Market size and forecast 2023-2028 ($ billion)
Data Table on Muscle injection - Market size and forecast 2023-2028 ($ billion)
Chart on Muscle injection - Year-over-year growth 2023-2028 (%)
Data Table on Muscle injection - Year-over-year growth 2023-2028 (%)
7.5 Subcutaneous injection - Market size and forecast 2023-2028
Chart on Subcutaneous injection - Market size and forecast 2023-2028 ($ billion)
Data Table on Subcutaneous injection - Market size and forecast 2023-2028 ($ billion)
Chart on Subcutaneous injection - Year-over-year growth 2023-2028 (%)
Data Table on Subcutaneous injection - Year-over-year growth 2023-2028 (%)
7.6 Market opportunity by Type
Market opportunity by Type ($ billion)
Data Table on Market opportunity by Type ($ billion)

8 Customer Landscape
8.1 Customer landscape overview
Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape
9.1 Geographic segmentation
Chart on Market share By Geographical Landscape 2023-2028 (%)
Data Table on Market share By Geographical Landscape 2023-2028 (%)
9.2 Geographic comparison
Chart on Geographic comparison
Data Table on Geographic comparison
9.3 North America - Market size and forecast 2023-2028
Chart on North America - Market size and forecast 2023-2028 ($ billion)
Data Table on North America - Market size and forecast 2023-2028 ($ billion)
Chart on North America - Year-over-year growth 2023-2028 (%)
Data Table on North America - Year-over-year growth 2023-2028 (%)
9.4 Asia - Market size and forecast 2023-2028
Chart on Asia - Market size and forecast 2023-2028 ($ billion)
Data Table on Asia - Market size and forecast 2023-2028 ($ billion)
Chart on Asia - Year-over-year growth 2023-2028 (%)
Data Table on Asia - Year-over-year growth 2023-2028 (%)
9.5 Europe - Market size and forecast 2023-2028
Chart on Europe - Market size and forecast 2023-2028 ($ billion)
Data Table on Europe - Market size and forecast 2023-2028 ($ billion)
Chart on Europe - Year-over-year growth 2023-2028 (%)
Data Table on Europe - Year-over-year growth 2023-2028 (%)
9.6 Rest of World (ROW) - Market size and forecast 2023-2028
Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
9.7 US - Market size and forecast 2023-2028
Chart on US - Market size and forecast 2023-2028 ($ billion)
Data Table on US - Market size and forecast 2023-2028 ($ billion)
Chart on US - Year-over-year growth 2023-2028 (%)
Data Table on US - Year-over-year growth 2023-2028 (%)
9.8 China - Market size and forecast 2023-2028
Chart on China - Market size and forecast 2023-2028 ($ billion)
Data Table on China - Market size and forecast 2023-2028 ($ billion)
Chart on China - Year-over-year growth 2023-2028 (%)
Data Table on China - Year-over-year growth 2023-2028 (%)
9.9 Canada - Market size and forecast 2023-2028
Chart on Canada - Market size and forecast 2023-2028 ($ billion)
Data Table on Canada - Market size and forecast 2023-2028 ($ billion)
Chart on Canada - Year-over-year growth 2023-2028 (%)
Data Table on Canada - Year-over-year growth 2023-2028 (%)
9.10 Germany - Market size and forecast 2023-2028
Chart on Germany - Market size and forecast 2023-2028 ($ billion)
Data Table on Germany - Market size and forecast 2023-2028 ($ billion)
Chart on Germany - Year-over-year growth 2023-2028 (%)
Data Table on Germany - Year-over-year growth 2023-2028 (%)
9.11 Japan - Market size and forecast 2023-2028
Chart on Japan - Market size and forecast 2023-2028 ($ billion)
Data Table on Japan - Market size and forecast 2023-2028 ($ billion)
Chart on Japan - Year-over-year growth 2023-2028 (%)
Data Table on Japan - Year-over-year growth 2023-2028 (%)
9.12 Market opportunity By Geographical Landscape
Market opportunity By Geographical Landscape ($ billion)
Data Tables on Market opportunity By Geographical Landscape ($ billion)

10 Drivers, Challenges, and Opportunity/Restraints
10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
Impact of drivers and challenges in 2023 and 2028
10.4 Market opportunities/restraints

11 Competitive Landscape
11.1 Overview
11.2 Competitive Landscape
Overview on criticality of inputs and factors of differentiation
11.3 Landscape disruption
Overview on factors of disruption
11.4 Industry risks
Impact of key risks on business

12 Competitive Analysis
12.1 Companies profiled
Companies covered
12.2 Market positioning of companies
Matrix on companies position and classification
12.3 AbbVie Inc.
AbbVie Inc. - Overview
AbbVie Inc. - Product / Service
AbbVie Inc. - Key news
AbbVie Inc. - Key offerings
12.4 Amgen Inc.
Amgen Inc. - Overview
Amgen Inc. - Product / Service
Amgen Inc. - Key news
Amgen Inc. - Key offerings
12.5 AstraZeneca Plc
AstraZeneca Plc - Overview
AstraZeneca Plc - Product / Service
AstraZeneca Plc - Key news
AstraZeneca Plc - Key offerings
12.6 Biogen Inc.
Biogen Inc. - Overview
Biogen Inc. - Product / Service
Biogen Inc. - Key news
Biogen Inc. - Key offerings
12.7 Bristol Myers Squibb Co.
Bristol Myers Squibb Co. - Overview
Bristol Myers Squibb Co. - Product / Service
Bristol Myers Squibb Co. - Key news
Bristol Myers Squibb Co. - Key offerings
12.8 Eli Lilly and Co.
Eli Lilly and Co. - Overview
Eli Lilly and Co. - Product / Service
Eli Lilly and Co. - Key news
Eli Lilly and Co. - Key offerings
12.9 F. Hoffmann La Roche Ltd.
F. Hoffmann La Roche Ltd. - Overview
F. Hoffmann La Roche Ltd. - Business segments
F. Hoffmann La Roche Ltd. - Key news
F. Hoffmann La Roche Ltd. - Key offerings
F. Hoffmann La Roche Ltd. - Segment focus
12.10 Gilead Sciences Inc.
Gilead Sciences Inc. - Overview
Gilead Sciences Inc. - Product / Service
Gilead Sciences Inc. - Key news
Gilead Sciences Inc. - Key offerings
12.11 GlaxoSmithKline Plc
GlaxoSmithKline Plc - Overview
GlaxoSmithKline Plc - Business segments
GlaxoSmithKline Plc - Key news
GlaxoSmithKline Plc - Key offerings
GlaxoSmithKline Plc - Segment focus
12.12 Johnson and Johnson Services Inc.
Johnson and Johnson Services Inc. - Overview
Johnson and Johnson Services Inc. - Business segments
Johnson and Johnson Services Inc. - Key news
Johnson and Johnson Services Inc. - Key offerings
Johnson and Johnson Services Inc. - Segment focus
12.13 Merck and Co. Inc.
Merck and Co. Inc. - Overview
Merck and Co. Inc. - Business segments
Merck and Co. Inc. - Key news
Merck and Co. Inc. - Key offerings
Merck and Co. Inc. - Segment focus
12.14 Novartis AG
Novartis AG - Overview
Novartis AG - Business segments
Novartis AG - Key news
Novartis AG - Key offerings
Novartis AG - Segment focus
12.15 Pfizer Inc.
Pfizer Inc. - Overview
Pfizer Inc. - Product / Service
Pfizer Inc. - Key news
Pfizer Inc. - Key offerings
12.16 Sanofi SA
Sanofi SA - Overview
Sanofi SA - Business segments
Sanofi SA - Key news
Sanofi SA - Key offerings
Sanofi SA - Segment focus
12.17 Takeda Pharmaceutical Co. Ltd.
Takeda Pharmaceutical Co. Ltd. - Overview
Takeda Pharmaceutical Co. Ltd. - Product / Service
Takeda Pharmaceutical Co. Ltd. - Key news
Takeda Pharmaceutical Co. Ltd. - Key offerings

13 Appendix
13.1 Scope of the report
13.2 Inclusions and exclusions checklist
Inclusions checklist
Exclusions checklist
13.3 Currency conversion rates for US$
Currency conversion rates for US$
13.4 Research methodology
Research methodology
13.5 Data procurement
Information sources
13.6 Data validation
Data validation
13.7 Validation techniques employed for market sizing
Validation techniques employed for market sizing
13.8 Data synthesis
Data synthesis
13.9 360 degree market analysis
360 degree market analysis
13.10 List of abbreviations
List of abbreviations

Exhibits:
Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits5: Executive Summary - Chart on Market Segmentation by End-user
Exhibits6: Executive Summary - Chart on Market Segmentation by Type
Exhibits7: Executive Summary - Chart on Incremental Growth
Exhibits8: Executive Summary - Data Table on Incremental Growth
Exhibits9: Executive Summary - Chart on Company Market Positioning
Exhibits10: Parent Market
Exhibits11: Data Table on - Parent Market
Exhibits12: Market characteristics analysis
Exhibits13: Value Chain Analysis
Exhibits14: Offerings of companies included in the market definition
Exhibits15: Market segments
Exhibits16: Chart on Global - Market size and forecast 2023-2028 ($ billion)
Exhibits17: Data Table on Global - Market size and forecast 2023-2028 ($ billion)
Exhibits18: Chart on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits19: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits20: Historic Market Size - Data Table on Global Large Molecule Injectable Drugs Market 2018 - 2022 ($ billion)
Exhibits21: Historic Market Size - End-user Segment 2018 - 2022 ($ billion)
Exhibits22: Historic Market Size - Type Segment 2018 - 2022 ($ billion)
Exhibits23: Historic Market Size - Geography Segment 2018 - 2022 ($ billion)
Exhibits24: Historic Market Size - Country Segment 2018 - 2022 ($ billion)
Exhibits25: Five forces analysis - Comparison between 2023 and 2028
Exhibits26: Bargaining power of buyers - Impact of key factors 2023 and 2028
Exhibits27: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
Exhibits28: Threat of new entrants - Impact of key factors in 2023 and 2028
Exhibits29: Threat of substitutes - Impact of key factors in 2023 and 2028
Exhibits30: Threat of rivalry - Impact of key factors in 2023 and 2028
Exhibits31: Chart on Market condition - Five forces 2023 and 2028
Exhibits32: Chart on End-user - Market share 2023-2028 (%)
Exhibits33: Data Table on End-user - Market share 2023-2028 (%)
Exhibits34: Chart on Comparison by End-user
Exhibits35: Data Table on Comparison by End-user
Exhibits36: Chart on Hospital pharmacies - Market size and forecast 2023-2028 ($ billion)
Exhibits37: Data Table on Hospital pharmacies - Market size and forecast 2023-2028 ($ billion)
Exhibits38: Chart on Hospital pharmacies - Year-over-year growth 2023-2028 (%)
Exhibits39: Data Table on Hospital pharmacies - Year-over-year growth 2023-2028 (%)
Exhibits40: Chart on Retail pharmacies - Market size and forecast 2023-2028 ($ billion)
Exhibits41: Data Table on Retail pharmacies - Market size and forecast 2023-2028 ($ billion)
Exhibits42: Chart on Retail pharmacies - Year-over-year growth 2023-2028 (%)
Exhibits43: Data Table on Retail pharmacies - Year-over-year growth 2023-2028 (%)
Exhibits44: Chart on E-commerce - Market size and forecast 2023-2028 ($ billion)
Exhibits45: Data Table on E-commerce - Market size and forecast 2023-2028 ($ billion)
Exhibits46: Chart on E-commerce - Year-over-year growth 2023-2028 (%)
Exhibits47: Data Table on E-commerce - Year-over-year growth 2023-2028 (%)
Exhibits48: Market opportunity by End-user ($ billion)
Exhibits49: Data Table on Market opportunity by End-user ($ billion)
Exhibits50: Chart on Type - Market share 2023-2028 (%)
Exhibits51: Data Table on Type - Market share 2023-2028 (%)
Exhibits52: Chart on Comparison by Type
Exhibits53: Data Table on Comparison by Type
Exhibits54: Chart on Intravenous injection - Market size and forecast 2023-2028 ($ billion)
Exhibits55: Data Table on Intravenous injection - Market size and forecast 2023-2028 ($ billion)
Exhibits56: Chart on Intravenous injection - Year-over-year growth 2023-2028 (%)
Exhibits57: Data Table on Intravenous injection - Year-over-year growth 2023-2028 (%)
Exhibits58: Chart on Muscle injection - Market size and forecast 2023-2028 ($ billion)
Exhibits59: Data Table on Muscle injection - Market size and forecast 2023-2028 ($ billion)
Exhibits60: Chart on Muscle injection - Year-over-year growth 2023-2028 (%)
Exhibits61: Data Table on Muscle injection - Year-over-year growth 2023-2028 (%)
Exhibits62: Chart on Subcutaneous injection - Market size and forecast 2023-2028 ($ billion)
Exhibits63: Data Table on Subcutaneous injection - Market size and forecast 2023-2028 ($ billion)
Exhibits64: Chart on Subcutaneous injection - Year-over-year growth 2023-2028 (%)
Exhibits65: Data Table on Subcutaneous injection - Year-over-year growth 2023-2028 (%)
Exhibits66: Market opportunity by Type ($ billion)
Exhibits67: Data Table on Market opportunity by Type ($ billion)
Exhibits68: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits69: Chart on Market share By Geographical Landscape 2023-2028 (%)
Exhibits70: Data Table on Market share By Geographical Landscape 2023-2028 (%)
Exhibits71: Chart on Geographic comparison
Exhibits72: Data Table on Geographic comparison
Exhibits73: Chart on North America - Market size and forecast 2023-2028 ($ billion)
Exhibits74: Data Table on North America - Market size and forecast 2023-2028 ($ billion)
Exhibits75: Chart on North America - Year-over-year growth 2023-2028 (%)
Exhibits76: Data Table on North America - Year-over-year growth 2023-2028 (%)
Exhibits77: Chart on Asia - Market size and forecast 2023-2028 ($ billion)
Exhibits78: Data Table on Asia - Market size and forecast 2023-2028 ($ billion)
Exhibits79: Chart on Asia - Year-over-year growth 2023-2028 (%)
Exhibits80: Data Table on Asia - Year-over-year growth 2023-2028 (%)
Exhibits81: Chart on Europe - Market size and forecast 2023-2028 ($ billion)
Exhibits82: Data Table on Europe - Market size and forecast 2023-2028 ($ billion)
Exhibits83: Chart on Europe - Year-over-year growth 2023-2028 (%)
Exhibits84: Data Table on Europe - Year-over-year growth 2023-2028 (%)
Exhibits85: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
Exhibits86: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
Exhibits87: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits88: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits89: Chart on US - Market size and forecast 2023-2028 ($ billion)
Exhibits90: Data Table on US - Market size and forecast 2023-2028 ($ billion)
Exhibits91: Chart on US - Year-over-year growth 2023-2028 (%)
Exhibits92: Data Table on US - Year-over-year growth 2023-2028 (%)
Exhibits93: Chart on China - Market size and forecast 2023-2028 ($ billion)
Exhibits94: Data Table on China - Market size and forecast 2023-2028 ($ billion)
Exhibits95: Chart on China - Year-over-year growth 2023-2028 (%)
Exhibits96: Data Table on China - Year-over-year growth 2023-2028 (%)
Exhibits97: Chart on Canada - Market size and forecast 2023-2028 ($ billion)
Exhibits98: Data Table on Canada - Market size and forecast 2023-2028 ($ billion)
Exhibits99: Chart on Canada - Year-over-year growth 2023-2028 (%)
Exhibits100: Data Table on Canada - Year-over-year growth 2023-2028 (%)
Exhibits101: Chart on Germany - Market size and forecast 2023-2028 ($ billion)
Exhibits102: Data Table on Germany - Market size and forecast 2023-2028 ($ billion)
Exhibits103: Chart on Germany - Year-over-year growth 2023-2028 (%)
Exhibits104: Data Table on Germany - Year-over-year growth 2023-2028 (%)
Exhibits105: Chart on Japan - Market size and forecast 2023-2028 ($ billion)
Exhibits106: Data Table on Japan - Market size and forecast 2023-2028 ($ billion)
Exhibits107: Chart on Japan - Year-over-year growth 2023-2028 (%)
Exhibits108: Data Table on Japan - Year-over-year growth 2023-2028 (%)
Exhibits109: Market opportunity By Geographical Landscape ($ billion)
Exhibits110: Data Tables on Market opportunity By Geographical Landscape ($ billion)
Exhibits111: Impact of drivers and challenges in 2023 and 2028
Exhibits112: Overview on criticality of inputs and factors of differentiation
Exhibits113: Overview on factors of disruption
Exhibits114: Impact of key risks on business
Exhibits115: Companies covered
Exhibits116: Matrix on companies position and classification
Exhibits117: AbbVie Inc. - Overview
Exhibits118: AbbVie Inc. - Product / Service
Exhibits119: AbbVie Inc. - Key news
Exhibits120: AbbVie Inc. - Key offerings
Exhibits121: Amgen Inc. - Overview
Exhibits122: Amgen Inc. - Product / Service
Exhibits123: Amgen Inc. - Key news
Exhibits124: Amgen Inc. - Key offerings
Exhibits125: AstraZeneca Plc - Overview
Exhibits126: AstraZeneca Plc - Product / Service
Exhibits127: AstraZeneca Plc - Key news
Exhibits128: AstraZeneca Plc - Key offerings
Exhibits129: Biogen Inc. - Overview
Exhibits130: Biogen Inc. - Product / Service
Exhibits131: Biogen Inc. - Key news
Exhibits132: Biogen Inc. - Key offerings
Exhibits133: Bristol Myers Squibb Co. - Overview
Exhibits134: Bristol Myers Squibb Co. - Product / Service
Exhibits135: Bristol Myers Squibb Co. - Key news
Exhibits136: Bristol Myers Squibb Co. - Key offerings
Exhibits137: Eli Lilly and Co. - Overview
Exhibits138: Eli Lilly and Co. - Product / Service
Exhibits139: Eli Lilly and Co. - Key news
Exhibits140: Eli Lilly and Co. - Key offerings
Exhibits141: F. Hoffmann La Roche Ltd. - Overview
Exhibits142: F. Hoffmann La Roche Ltd. - Business segments
Exhibits143: F. Hoffmann La Roche Ltd. - Key news
Exhibits144: F. Hoffmann La Roche Ltd. - Key offerings
Exhibits145: F. Hoffmann La Roche Ltd. - Segment focus
Exhibits146: Gilead Sciences Inc. - Overview
Exhibits147: Gilead Sciences Inc. - Product / Service
Exhibits148: Gilead Sciences Inc. - Key news
Exhibits149: Gilead Sciences Inc. - Key offerings
Exhibits150: GlaxoSmithKline Plc - Overview
Exhibits151: GlaxoSmithKline Plc - Business segments
Exhibits152: GlaxoSmithKline Plc - Key news
Exhibits153: GlaxoSmithKline Plc - Key offerings
Exhibits154: GlaxoSmithKline Plc - Segment focus
Exhibits155: Johnson and Johnson Services Inc. - Overview
Exhibits156: Johnson and Johnson Services Inc. - Business segments
Exhibits157: Johnson and Johnson Services Inc. - Key news
Exhibits158: Johnson and Johnson Services Inc. - Key offerings
Exhibits159: Johnson and Johnson Services Inc. - Segment focus
Exhibits160: Merck and Co. Inc. - Overview
Exhibits161: Merck and Co. Inc. - Business segments
Exhibits162: Merck and Co. Inc. - Key news
Exhibits163: Merck and Co. Inc. - Key offerings
Exhibits164: Merck and Co. Inc. - Segment focus
Exhibits165: Novartis AG - Overview
Exhibits166: Novartis AG - Business segments
Exhibits167: Novartis AG - Key news
Exhibits168: Novartis AG - Key offerings
Exhibits169: Novartis AG - Segment focus
Exhibits170: Pfizer Inc. - Overview
Exhibits171: Pfizer Inc. - Product / Service
Exhibits172: Pfizer Inc. - Key news
Exhibits173: Pfizer Inc. - Key offerings
Exhibits174: Sanofi SA - Overview
Exhibits175: Sanofi SA - Business segments
Exhibits176: Sanofi SA - Key news
Exhibits177: Sanofi SA - Key offerings
Exhibits178: Sanofi SA - Segment focus
Exhibits179: Takeda Pharmaceutical Co. Ltd. - Overview
Exhibits180: Takeda Pharmaceutical Co. Ltd. - Product / Service
Exhibits181: Takeda Pharmaceutical Co. Ltd. - Key news
Exhibits182: Takeda Pharmaceutical Co. Ltd. - Key offerings
Exhibits183: Inclusions checklist
Exhibits184: Exclusions checklist
Exhibits185: Currency conversion rates for US$
Exhibits186: Research methodology
Exhibits187: Information sources
Exhibits188: Data validation
Exhibits189: Validation techniques employed for market sizing
Exhibits190: Data synthesis
Exhibits191: 360 degree market analysis
Exhibits192: List of abbreviations

この商品のレポートナンバー

0000040410

TOP